The data show that FL-L1CAM and SV-L1CAM mRNAs are both expressed in benign ovarian tumours and both increased during progression of human ovarian carcinomas and were highest in ovarian carcinoma peritoneal metastases (Fig. 1A and B). The gene discussed is L1CAM; the disease is ovarian carcinoma.